Satoru Nakatani1, Akira Murakami2. 1. Department of Ophthalmology, Juntendo University Graduate School of Medicine, 3-1-3 Hongo Bunkyo-ku, Tokyo, Japan, 113-8431. satoru-n@juntendo.ac.jp. 2. Department of Ophthalmology, Juntendo University Graduate School of Medicine, 3-1-3 Hongo Bunkyo-ku, Tokyo, Japan, 113-8431.
Abstract
PURPOSE: To evaluate the outcomes of Descemet stripping automated endothelial keratoplasty (DSAEK) using corneas from elderly donors. METHODS: A total of 90 eyes that underwent DSAEK at Juntendo University Hospital between January 2008 and December 2012 were divided into two groups. Group 1 was eyes that received corneas from elderly donors aged 80 years or older (29 eyes), and group 2 was eyes that received corneas from donors aged 79 years or younger (61 eyes). Patient characteristics and visual acuity, endothelial cell density, and postoperative complications at 2 years after surgery were examined retrospectively. RESULTS: The mean age of the donors was 86.3 ± 28.9 years (range, 80-98 years) in group 1 and 62.1 ± 23.2 years (range, 26-79 years) in group 2. At 2 years after surgery, median logMAR visual acuity was 0.48 ± 0.38 in group 1 and 0.42 ± 0.47 in group 2, while the median loss of endothelial cell density was 38.9 ± 22.5 % and 39.7 ± 23.8 %, respectively. There was no significant difference between the two groups for all the parameters. CONCLUSIONS: The rate of endothelial cell loss at 2 years after surgery was similar regardless of donor age (≥80 years vs ≤79 years). It seems reasonable to use corneas from donors aged 80 years or older for DSAEK provided the selection criteria are fulfilled.
PURPOSE: To evaluate the outcomes of Descemet stripping automated endothelial keratoplasty (DSAEK) using corneas from elderly donors. METHODS: A total of 90 eyes that underwent DSAEK at Juntendo University Hospital between January 2008 and December 2012 were divided into two groups. Group 1 was eyes that received corneas from elderly donors aged 80 years or older (29 eyes), and group 2 was eyes that received corneas from donors aged 79 years or younger (61 eyes). Patient characteristics and visual acuity, endothelial cell density, and postoperative complications at 2 years after surgery were examined retrospectively. RESULTS: The mean age of the donors was 86.3 ± 28.9 years (range, 80-98 years) in group 1 and 62.1 ± 23.2 years (range, 26-79 years) in group 2. At 2 years after surgery, median logMAR visual acuity was 0.48 ± 0.38 in group 1 and 0.42 ± 0.47 in group 2, while the median loss of endothelial cell density was 38.9 ± 22.5 % and 39.7 ± 23.8 %, respectively. There was no significant difference between the two groups for all the parameters. CONCLUSIONS: The rate of endothelial cell loss at 2 years after surgery was similar regardless of donor age (≥80 years vs ≤79 years). It seems reasonable to use corneas from donors aged 80 years or older for DSAEK provided the selection criteria are fulfilled.
Authors: P Gain; G Thuret; C Chiquet; P Rizzi; J L Pugniet; S Acquart; J J Colpart; J C Le Petit; J Maugery Journal: Br J Ophthalmol Date: 2002-04 Impact factor: 4.638
Authors: Sonja Heinzelmann; Silja Hüther; Daniel Böhringer; Philipp Eberwein; Thomas Reinhard; Philip Maier Journal: Cornea Date: 2014-06 Impact factor: 2.651
Authors: Robin L gal; Mariya Dontchev; Roy W Beck; Mark J Mannis; Edward J Holland; Craig Kollman; Steven P Dunn; Ellen L Heck; Jonathan H Lass; Monty M Montoya; Robert L Schultze; R Doyle Stulting; Alan Sugar; Joel Sugar; Bradley Tennant; David D Verdier Journal: Ophthalmology Date: 2008-04 Impact factor: 12.079
Authors: Jonathan H Lass; Robin L Gal; Mariya Dontchev; Roy W Beck; Craig Kollman; Steven P Dunn; Ellen Heck; Edward J Holland; Mark J Mannis; Monty M Montoya; Robert L Schultze; R Doyle Stulting; Alan Sugar; Joel Sugar; Bradley Tennant; David D Verdier Journal: Ophthalmology Date: 2008-04 Impact factor: 12.079
Authors: Mark J Mannis; Edward J Holland; Robin L Gal; Mariya Dontchev; Craig Kollman; Dan Raghinaru; Steven P Dunn; Robert L Schultze; David D Verdier; Jonathan H Lass; Irving M Raber; Joel Sugar; Mark S Gorovoy; Alan Sugar; R Doyle Stulting; Monty M Montoya; Jeffrey G Penta; Beth Ann Benetz; Roy W Beck Journal: Ophthalmology Date: 2013-12 Impact factor: 12.079